Role of Cytokines in Sepsis (Q41610123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Role of cytokines in sepsis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Role of Cytokines in Sepsis (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

19 November 2024

0 references

C. E. Hack

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9328641

19 November 2024

L. A. Aarden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9328641

19 November 2024

L. G. Thijs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9328641

19 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9328641

19 November 2024

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9328641

19 November 2024

published in

Advances in Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

101-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

Pathophysiology of bacteremia

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The cardiovascular response of normal humans to the administration of endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

IL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 and its receptor: a paradigm for cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cachectin: more than a tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of cachectin/TNF in endotoxic shock and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Management of septic shock: present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Studies on the role of tumor necrosis factor in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Structure of tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

In vitro processing of human tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Human interleukin 1. Purification to homogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification and partial biochemical characterization of normal human interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Modalities for reducing interleukin 1 activity in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Role of interleukin-1 in infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identification of a monocyte specific pre-interleukin 1 beta convertase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning of the interleukin-1 beta converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Structure and mechanism of interleukin-1 beta converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cell suicide: by ICE, not fire

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Key mediator takes shape

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A Synthetic Inhibitor of Interleukin-lβ Converting Enzyme Prevents Endotoxin-Induced Interleukin-lβ ProductionIn VitroandIn Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

1 reference

7 January 2021

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning and expression of a receptor for human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Two high-affinity interleukin 1 receptors represent separate gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of interleukin-1 in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The two interleukin-1 receptors play different roles in IL-1 actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Degradation of interleukin 1beta by matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Polymorphonuclear granulocytes enhance lipopolysaccharide‐induced soluble p75 tumor necrosis factor receptor release from mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification and characterization of a novel soluble receptor for interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

IL-1 receptor antagonist release is regulated differently in human alveolar macrophages than in monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumour necrosis factor-alpha: its role in the metabolic response to sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Dysregulation of in vitro cytokine production by monocytes during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

TNF modulates endothelial properties by decreasing cAMP

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transcriptional regulation of tissue factor expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cytokines as communication signals between leukocytes and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prostacyclin synthesis induced in vascular cells by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The effect of tumor necrosis factor on vascular smooth muscle. In vitro studies using rat aortic rings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 beta and tumor necrosis factor-alpha stimulate the cat-2 gene of the L-arginine transporter in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transcriptional regulation of the endothelin-1 gene by TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Expression of human neutrophil L-selectin during the systemic inflammatory response syndrome is partly mediated by tumor factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Release of soluble intercellular adhesion molecule 1 into bile and serum in murine endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activation of coagulation after administration of tumor necrosis factor to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Fibrinolytic response to tumor necrosis factor in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effects of interleukins on plasma arginine vasopressin and oxytocin levels in conscious, freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Complement activation and high-dose of interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cytokine-Stimulated Nitric Oxide Production Inhibits Mitochondrial Activity in Cardiac Myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor-alpha induces a biphasic effect on myocardial contractility in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Oxpentifylline in endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Ibuprofen attenuates plasma tumor necrosis factor activity during sepsis-induced acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endotoxin infusion in anesthetized sheep is associated with intrapulmonary sequestration of leukocytes that immunohistochemically express tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Thrombomodulin release in baboon sepsis: its dependence on the dose of Escherichia coli and the presence of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The production of cytokines by polymorphonuclear neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prevention of endotoxin shock by an antibody against leukocyte integrin beta 2 through inhibiting production and action of TNF

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 reduces mortality from severe peritonitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Critical protective role of mast cells in a model of acute septic peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

PEG-BP-30 Monotherapy Attenuates the Cytokine-Mediated Inflammatory Cascade in Baboon Escherichia coli Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor antibody treatment of septic baboons reduces the production of sustained T-cell suppressive factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of the biologic activity of tumor necrosis factor maintains vascular endothelial cell function during hyperdynamic sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 receptor blockade attenuates the host inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Serum Cytokine Levels in Human Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Definition of a new score for severity of generalizedNeisseria meningitidis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor and septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Dissociation between plasma and monocyte-associated cytokines during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pattern of soluble TNF receptors I and II in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interactions between cytokines and α2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cytokine measurements in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Circulating interleukin-6 receptor in patients with sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monoclonal antibody to TNF in severe septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

CDP571, a humanized antibody to human tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 Blockade Attenuates Mediator Release and Dysregulation of the Hemostatic Mechanism During Human Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 mediates increased plasma levels of eicosanoids and cytokines in patients with sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Human chromosome 7 carries the beta 2 interferon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Haemopoietic receptors and helical cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning and expression of an IL-6 signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 6 is involved in interleukin 1-induced activities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of rat acute-phase proteins by interleukin 6 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Multiple actions of interleukin 6 within a cytokine network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Defective inflammatory response in interleukin 6-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Serum levels of interleukin-6 and acute phase responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activation of neutrophils by recombinant interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

C-reactive protein reactivity with complement and effects on phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Dose-dependent increase in plasma interleukin-6 after recombinant tumour necrosis factor infusion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Novel neutrophil-stimulating peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning of complementary DNA encoding a functional human interleukin-8 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Structure and Functional Expression of a Human Interleukin-8 Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nitric oxide regulation of IL-8 expression in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Thrombin induces GRO alpha/MGSA production in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activated platelets signal chemokine synthesis by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anoxia-hyperoxia induces monocyte-derived interleukin-8

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Regulation of Rransendothelial Neutrophil Migration by Endogenous Interleukin-8

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

IL-8 as a circulating cytokine: induction by recombinant tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Essential involvement of interleukin-8 (IL-8) in acute inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysacchari

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Increased levels of circulating interleukin-8 in patients with large burns: relation to burn size and sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 8-related neutrophil elastase and the severity of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Levels of interleukin-8 in patients with adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Role of selectiris In development of adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 protects mice from lethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 production during septicaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 Is Associated with the Development of Sepsis in Trauma Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 4 prevents the induction of tissue factor mRNA in human monocytes in response to LPS or PMA stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of macrophage-activating cytokines is beneficial in the acute septic response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transforming growth factor-beta and interleukin-10, but not interleukin-4, down-regulate procoagulant activity and tissue factor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Association of Interleukin-4 Plasma Levels With Traumatic Injury and Clinical Course

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Structure of the human immune interferon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 12: a new clinical player in cytokine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning of a new cytokine that induces IFN-gamma production by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of interleukin 12 in the immune response, disease and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

IL-12 rescues galactosamine-loaded mice from lethal shock triggered by staphylococcal enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon-alpha prevents endotoxin-induced mortality in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon beta, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

LIF: lots of interesting functions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of cytokine expression by leukemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

MIF as a glucocorticoid-induced modulator of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Treatment of Cancer Patients with Endotoxin Induces Release of Endogenous Cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effect of granulocyte colony-stimulating factor on acute lung injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effect of recombinant human granulocyte colony-stimulating factor on hemodynamic and cytokine response in a porcine model of Pseudomonas sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

GM-CSF rapidly primes mice for enhanced cytokine production in response to LPS and TNF

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocyte–macrophage colony-stimulating factor modulates immune function and improves survival after experimental thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The release of interleukin-8 during intravenous bolus treatment with interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 in biology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Alterations of neutrophil responses to tumor necrosis factor alpha and interleukin-8 following human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-8 in sepsis: relation to shock and inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High levels of interleukin 10 in serum are associated with fatality in meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Role of gamma interferon in a neonatal mouse model of group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern

11

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy

19 November 2024

72

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist

19 November 2024

109

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects

19 November 2024

127

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Platelet-activating factor and cytokine production in the perfused rat liver

19 November 2024

132

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice

19 November 2024

140

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin beta 2 with concomitant reduction of cytokine production

19 November 2024

141

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Regulation of the pathophysiology of tumor necrosis factor

19 November 2024

149

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells

19 November 2024

164

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells

19 November 2024

169

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Acute in vivo effects of human recombinant tumor necrosis factor

19 November 2024

200

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro

19 November 2024

205

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis

19 November 2024

210

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration

19 November 2024

215

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy

19 November 2024

220

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

A single dose of endotoxin activates neutrophils without activating complement

19 November 2024

241

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Cytokine appearance in human endotoxemia and primate bacteremia

19 November 2024

264

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli

19 November 2024

285

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists

19 November 2024

303

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation

19 November 2024

305

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Sepsis-induced cascade of cytokine mRNA expression: correlation with metabolic changes

19 November 2024

312

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration

19 November 2024

337

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Big-endothelin release in baboon bacteremia is partially TNF dependent

19 November 2024

350

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation

19 November 2024

357

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality

19 November 2024

368

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Serum tumor necrosis factor levels in patients with infectious disease and septic shock

19 November 2024

369

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Interleukin-6 and the acute phase response

19 November 2024

437

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

The acute phase response of the liver in inflammation

19 November 2024

439

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients

19 November 2024

445

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation

19 November 2024

451

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons

19 November 2024

458

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes

19 November 2024

507

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin

19 November 2024

511

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells

19 November 2024

514

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes

19 November 2024

520

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock

19 November 2024

542

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon- gamma

19 November 2024

596

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Participation of IFN-gamma in the pathogenesis of LPS lethality

19 November 2024

600

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema

19 November 2024

602

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri)

19 November 2024

618

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment

19 November 2024

661

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60597-0

19 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference